PVR and melanoma: TIGIT binds two ligands, CD112 (nectin-2, also known as PRR2 or PVRL2) and, with much higher affinity, CD155 (PVR or Necl-5), both identified on APCs, T cells and a variety of non-hematopoietic cell types including melanoma cells [57].